Task: Answer the multiple choice question.
Question: Which compound exhibits a -25.086\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) COCCCNC(=O)CSc1nc2c(sc3ccccc32)c(=O)n1CCCC(=O)NCC1CCCO1
b.) CN(C)CCCN(C(=O)C1=COCCO1)c1nc2ccc(Br)cc2s1.Cl
Answer: b. CN(C)CCCN(C(=O)C1=COCCO1)c1nc2ccc(Br)cc2s1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C)CCCN(C(=O)C1=COCCO1)c1nc2ccc(Br)cc2s1.Cl
CN(C)CCCN(C(=O)C1=COCCO1)c1nc2ccc(Br)cc2s1.Cl
N-(6-bromo-1,3-benzothiazol-2-yl)-N-[3-(dimethylamino)propyl]-2,3-dihydro-1,4-dioxine-5-carboxamide;hydrochloride